Cedars-Sinai Medical Center

Oncology & Cancer

Identifying the underlying causes of ovarian cancer

Two new discoveries led by Cedars-Sinai Cancer investigators help improve the understanding of what drives the development of ovarian cancer and why some women's tumors do not respond to therapy.

Neuroscience

Stem cell-gene therapy shows promise in ALS safety trial

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially ...

Cardiology

Sex differences and AFib: New study flips conventional wisdom

Science has long shown that men are at greater risk for developing atrial fibrillation (AFib) than women; but it has never been fully understood why women would be protected from developing the condition. New research from ...

Inflammatory disorders

New method detects gut microbes that activate immune cells

Cedars-Sinai investigators have developed a method to help identify which human gut microbes are most likely to contribute to a slew of inflammatory diseases like obesity, liver disease, inflammatory bowel disease, cancer ...

Diseases, Conditions, Syndromes

Study: Most people infected with omicron didn't know it

The majority of people who were likely infected with the omicron variant of SARS-CoV-2, the virus that causes COVID-19, didn't know they had the virus, according to a new study from Cedars-Sinai investigators. The findings ...

Neuroscience

Researchers create most realistic computer models of brain cells

Cedars-Sinai investigators have created the most bio-realistic and complex computer models of individual brain cells—in unparalleled quantity. Their research, published today in the peer-reviewed journal Cell Reports, details ...

Oncology & Cancer

How tumors make immune cells 'go bad'

Investigators from Cedars-Sinai Cancer have discovered that cancerous tumors called soft-tissue sarcomas produce a protein that switches immune cells from tumor-attacking to tumor-promoting. The study, published today in ...

Oncology & Cancer

Study uncovers new treatment approaches for liver cancer patients

Experts from Cedars-Sinai Cancer have analyzed patient samples, along with studies conducted in animal models, to identify a novel immune checkpoint pathway to treat hepatocellular carcinoma, the most common form of liver ...

page 5 from 36